CLAIMS - Clinical Impact through AI-assisted MS care

𝗖𝗟𝗔𝗜𝗠𝗦 - 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗺𝗽𝗮𝗰𝘁 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗔𝗜-𝗮𝘀𝘀𝗶𝘀𝘁𝗲𝗱 𝗠𝗦 𝗰𝗮𝗿𝗲 The CLAIMS project aims to address the urgent need for a more data-driven and personalized clinical decision-support tool for patients with 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗦𝗰𝗹𝗲𝗿𝗼𝘀𝗶𝘀, one that addresses the new insights in disease worsening due to both relapses and disease progression independent of relapses, and as such supports optimal treatment decisions and improved long-term patient outcomes. As such, our mission is to develop, validate, and seek regulatory approval for a 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗼𝗻 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 that provides a holistic view of each patient. This platform will visualize existing and new biomarker data, as well as predict disease trajectories under different treatment scenarios while accounting for comorbidities. Powered by deep-learning-based disease 𝘀𝘂𝗯𝘁𝘆𝗽𝗶𝗻𝗴 and 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻 models, this platform aims to enhance the precision of MS care, extending the patients’ quality-adjusted life years, and reducing the economic burden on both individuals and society. CLAIMS is supported by the Innovative Health Initiative Joint Undertaking (JU) under grant agreement No 101112153. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, EuropaBio, MedTech Europe, Vaccines Europe, AB Science SA and icometrix NV.